Risk of Neuroinflammatory Adverse Events With Tumor Necrosis Factor Inhibitor Treatment

Factor Inhibitor ◽

Necrosis Factor ◽

Comparison of latent tuberculosis infection screening strategies before tumor necrosis factor inhibitor treatment in inflammatory arthritis: IGRA-alone versus combination of TST and IGRA

PLoS ONE ◽

10.1371/journal.pone.0198756 ◽

2018 ◽

Vol 13 (7) ◽

pp. e0198756 ◽

Cited By ~ 3

Author(s):

Dae Hyun Jeong ◽

Jieun Kang ◽

Young Ju Jung ◽

Bin Yoo ◽

Chang-Keun Lee ◽

...

Keyword(s):

Tumor Necrosis Factor ◽

Inflammatory Arthritis ◽

Tumor Necrosis ◽

Latent Tuberculosis Infection ◽

Latent Tuberculosis ◽

Screening Strategies ◽

Factor Inhibitor ◽

Necrosis Factor ◽

Profiling Response to Tumor Necrosis Factor Inhibitor Treatment in Axial Spondyloarthritis

Arthritis Care & Research ◽

10.1002/acr.23465 ◽

2018 ◽

Vol 70 (9) ◽

pp. 1393-1399 ◽

Cited By ~ 1

Author(s):

Mansour Alazmi ◽

Ismail Sari ◽

Bharath Krishnan ◽

Robert D. Inman ◽

Nigil Haroon

Keyword(s):

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Axial Spondyloarthritis ◽

Factor Inhibitor ◽

Necrosis Factor ◽

FRI0450 Tumor Necrosis Factor Inhibitor Treatment in Psoriatic Arthritis: Need for Co-Medication?

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2016-eular.3115 ◽

2016 ◽

Vol 75 (Suppl 2) ◽

pp. 599.1-599

Author(s):

B. Michelsen ◽

D.M. Soldal ◽

A. Kavanaugh ◽

D.L. Boyle ◽

G. Haugeberg

Keyword(s):

Psoriatic Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Factor Inhibitor ◽

Necrosis Factor ◽

OP0189 Tumor necrosis factor inhibitor treatment reduces spinal radiographic progression in ankylosing spondylitis by decreasing disease activity: a longitudinal analysis in a large prospective cohort

10.1136/annrheumdis-2017-eular.2571 ◽

2017 ◽

Author(s):

C Molnar ◽

A Scherer ◽

X Baraliakos ◽

M de Hooge ◽

R Micheroli ◽

...

Keyword(s):

Ankylosing Spondylitis ◽

Tumor Necrosis Factor ◽

Longitudinal Analysis ◽

Tumor Necrosis ◽

Radiographic Progression ◽

Factor Inhibitor ◽

Large Prospective Cohort ◽

Necrosis Factor ◽

Response to Letter Regarding Article, “Effect of Tumor Necrosis Factor Inhibitor Treatment on Proximal Right Coronary Chronic Total Occlusion in a Patient With Rheumatoid Arthritis”

Circulation ◽

10.1161/circulationaha.115.017047 ◽

2015 ◽

Vol 132 (13) ◽

Author(s):

Michael Behnes ◽

Ibrahim Akin ◽

Martin Borggrefe ◽

Dominik Traunwieser ◽

Hans Neuser ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Chronic Total Occlusion ◽

Tumor Necrosis ◽

Total Occlusion ◽

Factor Inhibitor ◽

Necrosis Factor ◽

Efficacy of Tofacitinib in Patients With Ulcerative Colitis by Prior Tumor Necrosis Factor Inhibitor Treatment Status: Results From OCTAVE Induction and Maintenance Studies

The American Journal of Gastroenterology ◽

10.14309/00000434-201710001-00640 ◽

2017 ◽

Vol 112 ◽

pp. S354 ◽

Cited By ~ 3

Author(s):

Marla C. Dubinsky ◽

Laurent Peyrin-Biroulet ◽

Gil Y. Melmed ◽

Jason K. Hou ◽

Deborah A. Woodworth ◽

...

Keyword(s):

Ulcerative Colitis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Treatment Status ◽

Factor Inhibitor ◽

Necrosis Factor ◽

Successful cessation of tumor necrosis factor inhibitor treatment in rheumatoid arthritis patients and potential predictors for early flare: An observational study in routine clinical care

Modern Rheumatology ◽

10.1080/14397595.2019.1702253 ◽

2020 ◽

Vol 30 (6) ◽

pp. 948-958

Author(s):

Taio Naniwa ◽

Shiho Iwagaitsu ◽

Mikiko Kajiura

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Observational Study ◽

Tumor Necrosis ◽

Clinical Care ◽

Routine Clinical Care ◽

Factor Inhibitor ◽

Necrosis Factor ◽

Concomitant disseminated histoplasmosis and disseminated tuberculosis after tumor necrosis factor inhibitor treatment: a case report

BMC Infectious Diseases ◽

10.1186/s12879-016-2097-7 ◽

2017 ◽

Vol 17 (1) ◽

Cited By ~ 8

Author(s):

Juan E. Muñoz-Oca ◽

Martha L. Villarreal Morales ◽

Aracelis Nieves-Rodriguez ◽

Lemuel Martínez-Bonilla

Keyword(s):

Case Report ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Disseminated Tuberculosis ◽

Disseminated Histoplasmosis ◽

Factor Inhibitor ◽

Necrosis Factor ◽

An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity

Arthritis & Rheumatology ◽

10.1002/art.40546 ◽

2018 ◽

Vol 70 (10) ◽

pp. 1557-1564 ◽

Cited By ~ 6

Author(s):

An Tran-Duy ◽

Marjan Ghiti Moghadam ◽

Martijn A. H. Oude Voshaar ◽

Harald E. Vonkeman ◽

Annelies Boonen ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Economic Evaluation ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Low Disease Activity ◽

Disease Remission ◽

Factor Inhibitor ◽

Necrosis Factor ◽

Association of Tumor Necrosis Factor Inhibitor Treatment With Reduced Indices of Subclinical Atherosclerosis in Patients With Psoriatic Disease

Arthritis & Rheumatology ◽

10.1002/art.40366 ◽

2018 ◽

Vol 70 (3) ◽

pp. 408-416 ◽

Cited By ~ 21

Author(s):

Lihi Eder ◽

Aditya A. Joshi ◽

Amit K. Dey ◽

Richard Cook ◽

Evan L. Siegel ◽

...

Keyword(s):

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Subclinical Atherosclerosis ◽

Psoriatic Disease ◽

Factor Inhibitor ◽

Necrosis Factor ◽